Business

Some people still prefer the J & J Covid-19 vaccine even after the US has been suspended.

The Johnson & Johnson Coronavirus Disease (COVID-19) vaccine will be found on March 3, 2021 at Northwell Health’s Southshore University Hospital in Bay Shore, NY.

Shannon Stapleton | Reuters

Fewer Americans say they prefer the Johnson & Johnson Covid-19 vaccine after the US temporarily stopped using it in April, but a new study shows that 17% of Americans still have it as their number one. It states that it is a choice.

This is down from 29% in March before the suspension, according to a series of surveys of more than 1,500 Americans conducted by global data and research firm Dynata for CNBC.

A suspension from April 13 to 23 was recommended while US regulators were investigating rare but serious cases of vaccine-related blood clots. The Food and Drug Administration and the US Centers for Disease Control and Prevention recommended resuming vaccine use after the CDC Advisory Group concluded that the benefits of shots outweighed the risks, but the risk of blood clots was under 50 years of age. I warned that the woman was higher.

In an interview after the CDC advisory vote on April 23, New York City Council member Mark Levine, who chairs the City Health Council Committee, said, “This is just one shot and a well-known brand name. “. I did talk to people who told me they were waiting for the vaccine until J & J returned to the market. “

According to a Dynata survey conducted April 24-27, more and more people said they preferred the Pfizer vaccine after J & J was suspended. Pfizer’s top choice went from 20% in March to 35% in April. Moderna vaccines went from 10% as the top choice in March to 17% in April, with 12 to 13 respondents preferting either vaccine that uses the same messenger RNA technology in two doses. There was relatively no change. %.

Not surprisingly, given the high risk of blood clots in women, their preference for the J & J vaccine dropped from 29% to 21% in men, compared to 28% to 14% in March in April. Most dropped to.

The J & J suspension occurred at the peak of daily vaccinations in the United States, with an average of more than 3 million vaccinations per day. According to Evercore ISI data, the United States recorded 1.2 million shots on Monday.

However, local officials told CNBC that it was difficult to tell how much the suspension affected vaccination rates.

In a telephone interview on April 19, Judge Lina Hidalgo of Harris County, Texas, said, “In a sense, I looked at people who were eager to get it. They wanted it.” Told.

According to a Dynata study, the number of Americans who said they had no plans or were undecided to get the vaccine decreased slightly from March to April. Those who did not plan to vaccinate decreased from 13% to 12%, and those on the fence decreased from 6.8% to 5.6%.

When asked why they are more likely to be vaccinated, 37% say they have more science to support the safety and efficacy of the vaccine, and 31% have more time to feel better about long-term effects. I answered. Only 8.1% said they would be persuaded if their employers needed vaccination.

Many universities have stated that they will require students to be vaccinated to come to campus in the fall, and a Dynata survey found that more than half of respondents between the ages of 18 and 24 agreed to vaccination requirements at school. It turned out to be a good idea to do. A little over a quarter opposed them.

–CNBC Harriet Taylor And Whitney Kushiazek Contributed to this article.

Some people still prefer the J & J Covid-19 vaccine even after the US has been suspended.

Source link Some people still prefer the J & J Covid-19 vaccine even after the US has been suspended.

Back to top button